These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18460636)

  • 1. Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective.
    Curcio D
    J Clin Microbiol; 2008 May; 46(5):1892-3. PubMed ID: 18460636
    [No Abstract]   [Full Text] [Related]  

  • 2. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.
    Nix DE; Matthias KR
    J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673
    [No Abstract]   [Full Text] [Related]  

  • 3. EUCAST technical note on tigecycline.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
    Clin Microbiol Infect; 2006 Nov; 12(11):1147-9. PubMed ID: 17063597
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
    Krueger WA; Kempf VA; Peiffer M; Nagele U; Unertl KE; Schroeder TH
    J Clin Microbiol; 2008 Feb; 46(2):817-20. PubMed ID: 18077630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tigecycline: 10 years of history and still in full force].
    Barberán J; Salso S; Alhambra A
    Rev Esp Quimioter; 2015 Apr; 28(2):61-78. PubMed ID: 25904513
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tigecycline: antimicrobial action, chemotherapeutic efficacy and adverse reactions].
    Nikitin AV
    Antibiot Khimioter; 2009; 54(1-2):63-6. PubMed ID: 19499721
    [No Abstract]   [Full Text] [Related]  

  • 7. High serum concentrations of cyclosporin related to administration of tigecycline.
    Stumpf AN; Schmidt C; Hiddemann W; Gerbitz A
    Eur J Clin Pharmacol; 2009 Jan; 65(1):101-3. PubMed ID: 18795273
    [No Abstract]   [Full Text] [Related]  

  • 8. Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2606-10. PubMed ID: 24879669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
    Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL
    Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033
    [No Abstract]   [Full Text] [Related]  

  • 10. Tigecycline: place in therapy and important considerations.
    Garrelts JC; Schroeder T
    Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574
    [No Abstract]   [Full Text] [Related]  

  • 11. Tigecycline pharmacokinetic/pharmacodynamic update.
    MacGowan AP
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i11-6. PubMed ID: 18684702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline : a critical safety review.
    Kaewpoowat Q; Ostrosky-Zeichner L
    Expert Opin Drug Saf; 2015 Feb; 14(2):335-42. PubMed ID: 25539800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline treatment for urinary tract infections: case report and literature review.
    Drekonja DM; Johnson JR
    J Chemother; 2011 Jun; 23(3):168-70. PubMed ID: 21742587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tigecycline: a new antibiotic in ongoing clinical development].
    Stahl JP
    Med Mal Infect; 2005 Feb; 35(2):62-7. PubMed ID: 15780894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline in critical care.
    Mullangi PK; Pankey GA
    Crit Care Clin; 2008 Apr; 24(2):365-75, x. PubMed ID: 18361951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2875-6. PubMed ID: 24879666
    [No Abstract]   [Full Text] [Related]  

  • 18. New antibiotic approved for MRSA.
    Senior K
    Lancet Infect Dis; 2005 Aug; 5(8):474. PubMed ID: 16094734
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
    Arroyo LA; Mateos I; González V; Aznar J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
    [No Abstract]   [Full Text] [Related]  

  • 20. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.